# SARS-CoV-2 testing at the Seattle Vaccine and Prevention CRS (30331)

> **NIH NIH UM1** · FRED HUTCHINSON CANCER RESEARCH CENTER · 2020 · $299,401

## Abstract

Project Summary/Abstract
On March 11, 2020, the World Health Organization declared that the rapid spread of the novel coronavirus,
SARS-CoV-2, and its associated disease, COVID-19, had become a global pandemic. The ongoing crisis calls
for the involvement of clinical research sites (CRSs) to work rapidly and efficiently toward therapeutic and
preventative measures to control the epidemic. Our CRS, the Seattle Vaccine Trials Unit (VTU), has vast prior
experience conducting observational cohort studies and phase 1-2b clinical trials of preventative HIV vaccines
and other HIV prevention modalities. We propose bringing this infrastructure and experience to the field of SARS-
CoV-2 clinical research. Our proposal is both to expand the scope of research activity at our CRS and to involve
new venues for protocol conduct. Onsite CRS activity will encompass natural history studies of recovered
COVID-19 patients, as well as early to late phase vaccine protocols. New venues will be opened and developed
in order to effectively conduct COVID-19 research with appropriate infection prevention procedures to prevent
SARS-CoV-2 transmission. Such new venues will include temporary structures that will provide capability to
conduct clinical research in areas with continued SARS-CoV-2 transmission as specific areas with outbreaks are
noted during the course of the epidemic.

## Key facts

- **NIH application ID:** 10166485
- **Project number:** 3UM1AI069481-14S1
- **Recipient organization:** FRED HUTCHINSON CANCER RESEARCH CENTER
- **Principal Investigator:** Margaret Juliana McElrath
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $299,401
- **Award type:** 3
- **Project period:** 2020-06-16 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10166485

## Citation

> US National Institutes of Health, RePORTER application 10166485, SARS-CoV-2 testing at the Seattle Vaccine and Prevention CRS (30331) (3UM1AI069481-14S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10166485. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*